Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.

Georg Nickenig; Jan Ostergren; Harry Struijker-Boudier

doi:10.3317/jraas.2006.017

Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.

Journal of the Renin-Angiotensin-Aldosterone System ◽

10.3317/jraas.2006.017 ◽

2006 ◽

Vol 7 (1) ◽

pp. S1 ◽

Cited By ~ 15

Author(s):

Georg Nickenig ◽

Jan Ostergren ◽

Harry Struijker-Boudier

Keyword(s):

Clinical Evidence ◽

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CORONARY ARTERY DISEASE AND NO CLINICAL EVIDENCE OF HEART FAILURE: A META-ANALYSIS OF RANDOMIZED-CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)61428-5 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1428

Author(s):

Vu Linh Hoang ◽

Daniel Addison ◽

Yochai Birnbaum ◽

Francisco Macedo ◽

Mahboob Alam

Keyword(s):

Clinical Evidence ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

Download Full-text

Angiotensin Receptor Blockers Tied to Ca Risk

Family Practice News ◽

10.1016/s0300-7073(10)70750-7 ◽

2010 ◽

Vol 40 (12) ◽

pp. 20-21

Author(s):

DIANA MAHONEY

Keyword(s):

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text

Faculty Opinions recommendation of Angiotensin receptor blockers: are they related to lung cancer?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718053215.793485937 ◽

2013 ◽

Author(s):

Alberto Morganti

Keyword(s):

Lung Cancer ◽

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Angiotensin Converting Enzyme ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Faculty Opinions recommendation of Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732240576.793542016 ◽

2018 ◽

Author(s):

Tahir Hussain

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ace Inhibitors ◽

Angiotensin Receptor Blockers ◽

Renin Angiotensin System ◽

Lower Mortality ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Nationwide Study ◽

Receptor Blockers

Download Full-text

Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450

Current Drug Metabolism ◽

10.2174/1389200217666160524143843 ◽

2016 ◽

Vol 17 (7) ◽

pp. 681-691 ◽

Cited By ~ 13

Author(s):

Ruirui Yang ◽

Zhiqiang Luo ◽

Yang Liu ◽

Mohan Sun ◽

Ling Zheng ◽

...

Keyword(s):

Drug Interactions ◽

Cytochromes P450 ◽

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Cancer Epidemiology ◽

10.1016/j.canep.2009.10.005 ◽

2009 ◽

Vol 33 (5) ◽

pp. 391-395 ◽

Cited By ~ 14

Author(s):

E.R. Koomen ◽

R.M.C. Herings ◽

H.J. Guchelaar ◽

T. Nijsten

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Melanoma Incidence ◽

Receptor Blockers

Download Full-text

Antihypertensive, cardiovascular, and pleiotropic effects of angiotensin-receptor blockers

Current Opinion in Nephrology & Hypertension ◽

10.1097/01.mnh.0000174397.59100.89 ◽

2005 ◽

Vol 14 (5) ◽

pp. 435-441 ◽

Cited By ~ 30

Author(s):

Cristina Sierra ◽

Alejandro de la Sierra

Keyword(s):

Angiotensin Receptor Blockers ◽

Pleiotropic Effects ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Journal of Clinical Hypertension ◽

10.1111/jch.14329 ◽

2021 ◽

Author(s):

Na Jia ◽

Guifang Zhang ◽

Xuelin Sun ◽

Yan Wang ◽

Sai Zhao ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Systemic Review ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

All Cause Mortality ◽

Receptor Blockers

Download Full-text

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

Heart ◽

10.1136/hrt.86.1.97 ◽

2001 ◽

Vol 86 (1) ◽

pp. 97-103

Author(s):

John J V McMurray

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Acute Myocardial Infarction ◽

Chronic Heart Failure ◽

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Receptor Blockers

Download Full-text